Drugs / Methyloprednisolone
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02688985 Background | Apr 2016 → Apr 2023 | primary progressive multiple sclerosis | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Methyloprednisolone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02688985 ↗ |